🟢 Connect Biopharma is trading 12.37% up in after-hours trading amid broader market gains

Connect Biopharma is trading at $2.17, up 12.37%, amid broader risk-on sentiment.

• Shares fell 30.07% during the September 3 regular session; no new company-specific announcement explaining the after-hours rebound was identified.
• The S&P 500, Nasdaq Composite, and Dow Jones each gained more than 0.5% on September 3.
• Investors remain focused on anticipated September topline results from the Seabreeze STAT asthma and COPD studies.